Summary
GlobalData's clinical trial report, “Diabetic Gastroparesis Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Gastroparesis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Evoke Pharma, Inc.
Rhythm Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Ironwood Pharmaceuticals, Inc.
Ocera Therapeutics, Inc.
Novartis AG
ICON Plc
Eli Lilly and Company
Catalyst Biosciences, Inc.
Alfa Wassermann S.p.A
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Diabetic Gastroparesis Therapeutics Clinical Trials 24
Prominent Drugs 25
Latest Clinical Trials News on Diabetic Gastroparesis 26
May 03, 2016: Evoke Announces Timing of Phase 3 Results from its Recently Fully Enrolled Pivotal Clinical Trial of EVK-001 26
Apr 25, 2016: Evoke Successfully Completes Phase 3 Clinical Trial Enrollment of EVK-001 in Women with Symptoms Associated with Diabetic Gastroparesis 26
Apr 05, 2016: Ironwood Pharmaceuticals Reports Top-Line Data from Exploratory Phase IIa Study of IW-9179 in Diabetic Gastroparesis 26
Apr 04, 2016: Motus Completes Enrollment of Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis 27
Mar 01, 2016: Evoke Nears Completion of Phase 3 Clinical Trial Enrollment and Secures Extension to Credit Facility 27
Feb 17, 2016: Evoke Pharma to Present Results From Successful Thorough ECG (TQT) Study of EVK-001 at Digestive Disease Week 2016 27
Clinical Trial Profile Snapshots 29
Appendix 61
Abbreviations 61
Definitions 61
Research Methodology 62
Secondary Research 62
About GlobalData 63
Contact Us 63
Disclaimer 63
Source 64
List of Tables
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Region, 2016* 6
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Diabetic Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9
Diabetic Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Diabetic Gastroparesis Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Diabetic Gastroparesis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 13
Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 16
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Phase, 2016* 17
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 18
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25
List of Figures
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Diabetic Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 9
Diabetic Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Diabetic Gastroparesis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 13
Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 16
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 17
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 18
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25
GlobalData Methodology 62
